Columbus OH 黑色素瘤临床试验
21项针对 黑色素瘤的研究正在 Columbus及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
招募中3 期
- The Ohio State University Wexner Medical Center, Columbus
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
招募中3 期
- Ohio State University, Columbus
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
招募中1 期
- Ohio State University, Columbus
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
招募中2 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- 以及另外 15 项
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- 以及另外 8 项
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- The Ohio State University Comprehensive Cancer Center, Columbus
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
招募中1 期
- Ohio State University Comprehensive Cancer Center, Columbus
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
招募中1/2 期
- Ohio State University Comprehensive Cancer Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
招募中1/2 期
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
Neoadjuvant Darovasertib in Primary Uveal Melanoma
招募中3 期
- Ohio State Eye and Ear Institute, Columbus
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- The Ohio State University, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Memorial Hospital, Marysville · 距离 27 英里
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
招募中2 期
- Ohio State University Comprehensive Cancer Center, Columbus
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
招募中观察性研究欢迎健康志愿者
- The Ohio State University Wexner Medical Center, Columbus
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
招募中3 期
- The Ohio State University Comprehensive Cancer Center, Columbus
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
招募中观察性研究欢迎健康志愿者
- Ohio State University Comprehensive Cancer Center, Columbus
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
招募中3 期
- Ohio State University Wexner Medical Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- Ohio State University Comprehensive Cancer Center, Columbus
其他城市的 黑色素瘤试验
- Houston, TX59 项研究
- New York City, NY38 项研究
- Los Angeles, CA34 项研究
- Nashville, TN32 项研究
- Pittsburgh, PA31 项研究
- Boston, MA25 项研究
- Philadelphia, PA23 项研究
- San Francisco, CA22 项研究
- Atlanta, GA21 项研究
- Salt Lake City, UT21 项研究
- Durham, NC21 项研究
- Arlington, VA20 项研究
Columbus的其他研究
- 非小细胞肺癌55 项研究
- 癌症（所有类型）39 项研究
- 乳腺癌39 项研究
- 卵巢癌39 项研究
- 肺癌36 项研究
- 急性髓系白血病34 项研究
- 慢性淋巴细胞白血病29 项研究
- 转移性癌症27 项研究
- 子宫内膜癌26 项研究
- 结直肠癌24 项研究
- 多发性骨髓瘤24 项研究
- 前列腺癌24 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。